APA (7th ed.) Citation

Tawk, B., Wirkner, U., Schwager, C., Herpel, E., Tinhofer, I., Budach, V., . . . Abdollahi, A. (2020). Hypoxia Methylome Classifier (HDMC) Outperforms Gene Signatures in Identifying HPV-Negative HNSCC Patients at Risk for Locoregional Failure Post Primary Radiochemotherapy: A German Cancer Consortium Radiation Oncology Group (DKTK-ROG) Multicenter Trial. International Journal of Radiation Oncology, Biology, Physics, 108(3), e552. https://doi.org/10.1016/j.ijrobp.2020.07.1715

Chicago Style (17th ed.) Citation

Tawk, B., et al. "Hypoxia Methylome Classifier (HDMC) Outperforms Gene Signatures in Identifying HPV-Negative HNSCC Patients at Risk for Locoregional Failure Post Primary Radiochemotherapy: A German Cancer Consortium Radiation Oncology Group (DKTK-ROG) Multicenter Trial." International Journal of Radiation Oncology, Biology, Physics 108, no. 3 (2020): e552. https://doi.org/10.1016/j.ijrobp.2020.07.1715.

MLA (9th ed.) Citation

Tawk, B., et al. "Hypoxia Methylome Classifier (HDMC) Outperforms Gene Signatures in Identifying HPV-Negative HNSCC Patients at Risk for Locoregional Failure Post Primary Radiochemotherapy: A German Cancer Consortium Radiation Oncology Group (DKTK-ROG) Multicenter Trial." International Journal of Radiation Oncology, Biology, Physics, vol. 108, no. 3, 2020, p. e552, https://doi.org/10.1016/j.ijrobp.2020.07.1715.